Elixrbio
Elixrbio is a biotech company applying stem-cell and apoptosis biology to develop science-backed hair and skin self-care products. The company operates a research facility using advanced microscopy and an AI-driven computational platform to identify pathways behind graying and hair loss, with multiple patents pending across its platform.
- Biotechnology
- Consumer Goods
- Artificial Intelligence
- Healthcare Technology
- Software Only
- Wellness & Fitness Technology
Funding
Founders
Founder details are not available yet.
Product
Problem
Conventional skin and hair care products rely on superficial ingredients that do not target the underlying biological mechanisms of tissue renewal and follicle regeneration. Consumers lack effective, topically deliverable solutions that leverage the body's own stem-cell and apoptosis-driven repair pathways, leaving age-related hair loss and skin deterioration largely unaddressed.
Solution
Elixrbio applies stem-cell and apoptosis biology to create a new generation of self-care products that trigger the body's intrinsic renewal processes. The company has built a research facility for growing stem cells and organoids, visualized through multi-laser confocal and electron microscopy, to understand hair follicle neogenesis and skin repair at a cellular level. Using an AI-driven computational platform, it identifies the pathways behind graying and hair loss and screens bioactive compounds for topical delivery. Elixrbio's approach bridges biotech discovery and consumer products, ensuring that released formulations are rooted in validated molecular science rather than cosmetic claims.
Target Audience
Primary audiences are consumers seeking science-backed hair and skin regeneration products, along with investors, media, and researchers interested in the underlying biotech innovations.
Features
- Proprietary platform integrating stem-cell biology, apoptosis research, and regenerative medicine to target hair follicle neogenesis and tissue repair across the skin barrier
- State-of-the-art research lab with multi-laser confocal, inverted time-lapse fluorescence, scanning electron, and atomic-force microscopy for cellular and organoid imaging
- Computational, AI-driven design and screening platform that integrates biological data to identify pathways and bioactive compounds for graying and hair loss
- Expertise spanning melanocyte preservation, wound-induced hair neogenesis, and apoptotic-cell niche dynamics, supported by Helsinki-committee-approved human tissue research
- Multiple patents pending across the platform, with independent consumer research validating product efficacy